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Summary Cell killing of L1210 cells by cisplatin has been studied using flow cytometry and DNA gel
electrophoresis. Ten hours after a supralethal dose of drug (100tLM), extensive apoptosis was induced. Cells
were also susceptible to the induction of apoptosis by nutritional deprivation, for example by incubation in
arginine-deficient medium. After treatment in full medium with doses of drug in the range 1-1I 0 M, cells
experienced a slow-down in S-phase transit followed by a G2 block. Cells either overcame the G2 block and
continued to cycle or enlarged and eventually died. There was no evidence to suggest that cells dying from the
G2 block underwent apoptosis. The data were consistent with a dual mechanism of cell death - higher doses
of drug led to rapid death through apoptosis; lower doses led to death at later times resulting from failure to
overcome a block in G2.
The major cytotoxic lesion induced by cis-dichlorodiammine-
platinum(II) (cisplatin) is considered to be platination of the
DNA (Roberts & Thomson, 1979; Roberts & Friedlos, 1987),
leading to the introduction of interstrand (Roberts & Fried-
los, 1987; Eastman, 1985) and predominantly intrastrand
cross-links (Eastman, 1987). The subsequent repair of such
lesions is an important factor governing cytotoxicity (Fraval
& Roberts, 1979; Meyn et al., 1982; Roberts & Friedlos,
1987; Sorenson & Eastman, 1988a).
One of the early effects of the platination of DNA is a
reduction in the rate of DNA synthesis (Fraval & Roberts,
1978; Salles et al., 1983; Sorenson & Eastman, 1988a) and a
consequent slow-down in the traverse of cells through the
S-phase of their cycle; subsequently, there is a dose-
dependent arrest in G2 (Bergerat et al., 1979; Sorenson &
Eastman, 1988a,b; Fujikane et al., 1989; Demarcq et al.,
1992). It has been proposed that in G2 the cells reach a point
of decision at which they either overcome the G2 block,
divide and then cycle or remain in G2 and die (Sorenson &
Eastman, 1988a,b; Sorenson et al., 1990).
Apoptosis is a mode of cell death believed to account for
most or all of the programmed cell death responsible for
tissue modelling in vertebrate development (for example see
reviews by Wyllie et al., 1980; Arends & Wyllie, 1991; Wyllie,
1993). It is characterised morphologically by condensation of
nuclear chromatin, compaction of cytoplasmic organelles and
changes in the cell surface (Wyllie et al., 1980; Arends &
Wyllie, 1991). In many types of cell, particularly those of
lymphoid origin, during apoptosis nuclear DNA is digested
into oligonucleosomal length fragments (Wyllie, 1980),
although many morphological changes associated with apop-
tosis can be divorced from such DNA degradation (see, for
example, Cohen et al., 1992; Tomei et al., 1993). Recently it
has been proposed that apoptosis might be an important and
ubiquitous mode of cell death for cells treated with
chemotherapeutic drugs (Barry et al., 1990; Dive & Hickman,
1991; Hickman, 1992). Treatment with cisplatin has been
shown to induce apoptosis in Chinese hamster ovary and the
L1210 murine leukaemia cell lines (Barry et al., 1990; Soren-
son et al., 1990), and it has been postulated that cells blocked
in G2 of the cell cycle die through apoptosis (Sorenson et al.,
1990).
A better understanding of the mechanism of drug-induced
cytotoxicity is important since it would help in the design of
more effective chemotherapeutic agents and treatment regi-
mens. The purpose of this study was to use flow cytometry to
re-examine the mechanism by which cisplatin kills cells and
to explore the importance of apoptosis in cell death.
Materials and methods
Chemicals
Cisplatin was supplied by the Johnson Matthey Technology
Centre (Reading, Berks, UK), cell culture medium was pur-
chased from ICN FLOW (High Wycombe, Bucks, UK), agar
noble from Difco Laboratories (Detroit, MI, USA) and all
other reagents from Sigma (Poole, Dorset, UK).
Cells anddrug treatment
The L1210 murine leukaemia, grown in vivo, was a gift from
the National Cancer Institute (Bethesda, MD, USA). This
cell line was established in suspension culture in RPMI-1640
medium supplemented with 10% horse serum, 2 mM L-glut-
amine and antibiotics (100 U ml-I penicillin and 0.1 mg ml-'
streptomycin) (cell doubling time = 14 h). In experiments in
which cessation ofcell division was required, cells were trans-
ferred to Eagle's minimum essential medium (modified) with-
out arginine and supplemented with 2.5% dialysed fetal
bovine serum, 2 mM L-glutamine and antibiotics (as above).
Cisplatin was dissolved in 0.9% sterile saline immediately
prior to use. All experiments were initiated at a cell density
of 2 x I0 ml-'. Following exposure to cisplatin at different
concentrations for 2 h, cells were centrifuged at 800 g for
5 min, washed once with medium and resuspended in fresh
medium.
In cell survival assays, duplicate cultures of cells were
exposed to cisplatin for 2 h, washed, resuspended in fresh
medium and serially diluted to 2 x 102ml-'. Duplicate ali-
quots (2ml) were added to polypropylene tubes containing
3 ml of medium supplemented with 20% horse serum and
0.2% agar at 42°C. Tubes were plunged into iced water to set
the agar, incubated at 37'C for 7 days and colonies counted.
Plating efficiency of control cells was 83%.
In growth delay assays, triplicate cultures of treated cells
were washed and resuspended in fresh medium at a cell
density of 6 x 104 ml-'. Cell numbers were assessed over 96 h
using a Coulter counter (model ZM).
Flow cytometry
Flow cytometric measurements were made on an Ortho
Cytofluorograf 50H using a Spectra-Physics argon-ion laser
tuned to produce either 200 mW at 488 nm or 50 mW in the
UV. Data, normally from 2 x 104cells, were acquired and
analysed on an Ortho 2150 computer system. Univariate and
bivariate histograms (the latter referred to as cytograms)
were transferred to an IBM-compatible PC and figures
prepared using our own software (written by M.G.O.). For
the figures, the frequency scale was adjusted to optimise the
display of the data.
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Five detectors were available recording in a forward direc-
tion scattered light and orthogonally blue (488 nm, scattered
light; or 460 nm, fluorescence) and green (520 nm), orange
(570 nm) and red (>630 nm) fluorescences. If the red fluores-
cence was measuring DNA, then both the peak and the
integrated area of the fluorescent signal were recorded and
pulse shape analysis was performed to eliminate any cell
clumps (Ormerod, 1990).
For cell cycle analysis, approximately 106 cells were fixed
in ice-cold 70% ethanol and stored at 4°C. After washing,
cells were resuspended in 800 Ill of phosphate-buffered saline
(PBS) and 100 p1 of propidium iodide (PI) solution (100ytg
ml-') and 10011 of RNAse solution (1 mgml-') added
before incubation for 2 h at 37°C. The flow cytometer was
operated at 488 nm and, after pulse shape analysis and gating
on a cytogram of orthogonal vs forward light scatter, a
histogram of cell number against red (DNA-PI) fluorescence
was recorded.
For cell cycle analysis of live cells, approximately 106 cells
were incubated at 37°C for 20min in medium containing
10figml-' of the bis-benzimidazole dye, Hoechst 33342.
After centrifugation, cells were resuspended in PBS contain-
ing 5fig ml- PI. On the cytometer, cells were excited with
UV radiation and forward scatter, blue and red fluorescences
recorded. Dead cells which took up PI were excluded from
analysis by gating on red fluorescence before recording a
cytogram of blue fluorescence vs foward scatter.
To measure cell cycle progression, 501M bromodeoxy-
uridine (BrdU) was added to the cultures. Samples were
taken at different times, the cells centrifuged and resuspended
in ice-cold 100 mM Tris-HCl, 154 mM sodium chloride,
1 mM calcium chloride, 0.5 mM magnesium chloride, 0.1%
(v/v) Nonidet-P40, 0.2% (w/v) bovine serum albumin,
1.2 ig ml1' Hoechst 33258, pH 7.4; PI was added to a final
concentration of 2fig ml1 (Poot, 1990). UV radiation was
used for the flow cytometric analysis. After gating on a
cytogram of peak vs area of the red fluorescent (PI-DNA)
signal, a cytogram of red vs blue (Hoechst-DNA) fluores-
cence was recorded.
DNA gel electrophoresis
Approximately 3 x 105 cells were centrifuged and the pellet
resuspended in 30pl of DNA lysis buffer (200 mM Tris,
100 mM EDTA, 1% SDS, pH 8.5). Proteinase K solution
(3 ytl) at 1 mg ml-' was added and the mixture incubated at
37°C for 1 h. The mixture was incubated for a further hour
after the addition of 6 il of RNAse solution at 1 mg ml-'.
After the addition of 1 p1l of bromophenol blue solution and
20 1l of saturated sucrose, the mixture was passed twice
through a 23-G needle to shear the DNA and then applied to
the well of a horizontal 1% agarose gel. Electrophoresis was
performed, using 90 mM Tris, 90 mM boric acid, 2 mM
EDTA, 0.5fig ml-' ethidium bromide, pH 8.0, as running
buffer for 3h at 6Vcm-
Cell size distribution
Cell volume was measured using a Coulter counter (model
ZB) coupled to a dedicated multichannel analyser (Mevway
Electronics). Cell size distributions were produced using
purpose-written software following calibration of the Coulter
counter using latex beads of known volume.
Centrifugal elutriation
A Beckmann J2-21 centrifuge equipped with a JE-6B elutri-
ator rotor was used to separate the cell populations. Elutria-
tions were performed with full culture medium at 4°C. Cells
were loaded into the rotor at a flow rate of 13 mlminm- and
rotor speed of 2,500 r.p.m.; under these conditions all cells
larger than 250 ym3 were retained in the rotor chamber. The
small cell fraction (250-1250 tm3) was then elutriated from
the chamber by increasing flow rate to 35 ml min-'. This
fraction was collected in a total of 300 ml to ensure maximal
removal of cells of this size range. The remaining cells (the
large cell fraction > 1250tim3) were then collected from the
chamber by switching off the rotor and collecting a single
100 ml fraction.
Results
Cell survival
As measured by colony formation, the IC50 for a 2 h incuba-
tion with cisplatin was 2.1 ± 0.33jLM (six determinations;
range 1.5-2.4pM). A typical survival curve is shown in
Figure 1a. Growth curves measured over 4 days after treat-
ment with 0, 2, 5, 10 or 20tLM cisplatin are shown in Figure
lb. With a starting concentration of 6 x I04cells ml-', the
untreated cells reached plateau phase at 3 days.
Cell cycle analysis offixed cells
Cells, at different times after a 2 h incubation with cisplatin
in the dose range 3-1011M, were fixed in ethanol and their
DNA histograms recorded after staining with PI. In the first
12 h after treatment with the drug, the histograms showed a
dose-dependent reduction in cells in Gl and a concomitant
increase of cells in S. This was consistent with a slow-down
in transit through S-phase with little corresponding hindrance
of the GI -S phase transition. After 24 h a G2 block was
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Figure 1 L1210 cells treated for 2 h with cisplatin. a, Survival
curve assayed by colony formation. b, Growth curves: *, un-
treated cells; *, 21iM cisplatin; 0, 5iM cisplatin; A, 10jiM
cisplatin; A, 20 jIM cisplatin. The standard deviations are shown
where they exceeded the size of the symbols used for plotting.APOPTOSIS AND CELL DEATH BY CISPLATIN 95
clearly evident, being almost complete at a dose of 10pM. At
longer times of incubation, the percentage of cells in G2
progressively reduced until, by 72 h, the cell cycle was close
to that of normal cells. Typical histograms are shown in
Figure 2.
If the light scatter of the fixed cells was observed, in
untreated cells there was a single cluster but, at 24 h and
later times after treatment with 1OJM cisplatin, a separate
cluster of cells with higher light scatter appeared, being most
apparent after 2 days (Figure 3). This cluster contained cells
whose PI staining was greater (8%) than that of normal cells
in G2. The abnormal cluster was from oversized cells; it was
not caused by cell clumping since clumped cells could be
identified on a plot of the peak vs the integrated PI fluores-
cence and were gated out.
Cell cycle analysis oflive cells
In order to observe the cell cycle of viable cells only, unfixed
cells were incubated with the dye, Hoechst 33342, and PI
added before analysis. PI would be taken up only by cells
with damaged plasma membranes, that is dead cells. These
were excluded from further analysis. The results confirmed
that at later times there was a population of oversized cells in
G2/M of the cell cycle and that the DNA of these cells took
up more stain than normal cells in G2/M (Figure 4).
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Cell cycleprogression
Cells were incubated continuously with BrdU and the
permeabilised cells were stained with Hoechst 33352 and PI.
The red (PI-DNA) fluorescence identified the cell cycle com-
partment, while the blue (Hoechst DNA) fluorescence was
quenched by BrdU and identified those cells which had taken
up the thymidine analogue (Rabinovitch et al., 1988). A
detailed description of this method applied to asynchronous
cells has been given Ormerod and Kubbies (1992). Figure 5
shows typical cytograms obtained from untreated cells. With-
out BrdU, GI, S and G2/M phases of the cell cycle could be
identified from both the red (PI) and blue (Hoechst) fluores-
cence. After 3 h in BrdU, cells originally in G2/M had
divided and moved into GI (unlabelled). Cells in S-phase
showed increasing red fluorescence with cell cycle progression
but no increase in blue fluorescence (quenched by the BrdU).
At 8 h, all the cells now in S had been in GI at time 0 h (Sf
on the figure); some had progressed as far as G2/M (G2f)
and divided again (marked Gi'). There was a clear distinc-
tion between cells in GI which had divided after the addition
of BrdU (29%) and those which were still in their first cycle.
By 24 h, all the cells had divided and were progressing
through a second cycle.
Data obtained by adding BrdU immediately after treat-
ment with drug confirmed and added to the results shown by
the simple DNA histograms (two of the cytograms obtained
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Figure 2 DNA histograms from cells treated for 2 h with 1 pM a-c, 3gM d-f or 10 jAM g-i cisplatin. Histograms were recorded at
7 a, d, g, 24 b, e, h and 48 c, f, i h. DNA histograms from untreated cells are shown in Figure 6.
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are shown in Figure Se and f). At 8 h, most cells in G2 at the
time of treatment had divided; some cells from late S-phase
had progressed back to GI (9% of the total); cells treated in
mid- and early S-phase were held up in late S/G2 and
movement through S had slowed. By 24 h, nearly all the cells
which had been in GI and G2M at time 0 had progressed
through S and become blocked in G2 (G2f: 62% of the
total). Most cells treated in mid- and late S-phase had over-
come any G2 block and divided. (Cells treated in S phase
which had become blocked in G2 would have been to the
right of the position marked G2f in Figure Sf.)
If the BrdU was added 24h after treatment with 1O gM
cisplatin, only cells which had escaped the block in G2M
took up BrdU and a clear separation was obtained between
those cells which remained blocked in G2/M and those which
cycled normally (Figure 5g,h). There was evidence that a
minority of cells became blocked in G2 during their second
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Figure 3 Cells treated with 10 gM cisplatin for 2 h, incubated for
51 h in medium and fixed in ethanol. Cytogram of orthogonal
(side) vs forward light scatter together with the accompanying
DNA histograms of the individual clusters defined by light scat-
ter. Regions defining high (H) and low (L) light scatter are shown
on the cytogram. The DNA histograms of all the cells and of
cells in the clusters with low and high scatter are shown. The
numbers give the channel numbers of the G2/M peak (defined as
the mean channel across the peak). The cells with high scatter are
all in G2/M and have higher DNA fluorescence.
cycle (cells lying to the left of the cluster, 'G2', and marked
'G2*' in the cytogram in Figure 5h).
Detection ofapoptotic cells
In cells derived from lymphoid tissue, cells dying by apop-
tosis from GI give a 'sub-GI' (hypodiploid) peak in the
histogram (Ojeda et al., 1990; Rodriguez-Tarduchy et al.,
1990; Compton et al., 1988; Nicoletti et al., 1991; Telford et
al., 1991; 1992; Walker et al., 1991; Hotz et al., 1992; Bruno
et al., 1992; Jones & Lafrenz, 1992; Ormerod et al., 1992;
Darzynkiewicz et al., 1992), and this peak is closely
associated both with the DNA degradation symptomatic of
apoptosis ('DNA ladders'; Wyllie, 1980; Wyllie et al., 1980)
and morphological changes typical of apoptosis (Ormerod et
al., 1992; Darzynkiewicz et al., 1992). After doses of cisplatin
of 20 ltM and below, following further incubation in drug-
free medium up to 72 h, there was little evidence for a
'sub-GI' peak in the DNA histogram of for 'DNA ladders'
on gel electrophoresis. Apoptosis, as evidenced by a sub-GI
peak, DNA ladders and morphological changes, could be
induced by doses of cisplatin O 50 tLM (25 x IC50) or by
subjecting the cells to nutritional deprivation, such as incuba-
tion in arginine-deficient medium or incubation in PBS of
cells which were in or close to the plateau phase of growth
(Figure 6). The amount of apoptosis in untreated cells
induced by deprivation of nutrients was variable and
appeared to depend on the conditions of growth (cell density,
log vs plateau phase, Jiang et al., 1993). It was also enhanced
if the cells had previously been treated with 10 tLM cisplatin.
Separation ofsmall and large cells
The marked difference in size between cells blocked in G2/M
and cycling cells enabled them to be separated by centrifugal
elutriation. The larger cells could be seen in the cell size
distribution measured on a Coulter counter. Based on this
distribution, a cut-off was set at 13.5 jim diameter on the
elutriator and the cells separated into large and small frac-
tions. The individual fractions were then incubated in growth
medium for a further 3 days (a total of 5 days after drug
treatment). The DNA histograms recorded from cells before
and after centrifugal elutriation showed that a separation
between cells blocked in G2 and cycling cells had been
obtained (Figure 7). The large cells (those blocked in G2)
disappeared from the culture over 2 days, leaving cycling
cells. The fraction of small cells consisted predominantly of
normal cycling cells; an increase in G2/M after 1 day sug-
gested that a minority of the cells were held up in G2 (Figure
7e). A sub-GI peak was not evident in the DNA histogram
and, when samples were taken for DNA gel electrophoresis,
a faint DNA ladder could be discerned only in the sample
from small, cycling cells at day 5 (Figure 8b). Growth ofcells
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Figure 4 Cytograms of blue fluorescence vs forward light scatter of cells incubated with Hoechst 33342 and PI. Viable cells only
are shown - a gate was set on red (PI-positive) fluorescence to exclude dead cells. a, Untreated cells. b and c, IO JM cisplatin: b,
24 h post treatment; c, 48 h post treatment. The phases of the cell cycle are marked; aG2 = abnormal cells in G2/M (high light
scatter, increased blue fluorescence).
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Figure 5 L1210 cells incubated continuously with BrdU. Cytograms of red (PI-DNA) vs blue (Hoechst DNA) fluorescence after
staining permeabilised cells with Hoechst 33352 and PI. The cell cycle phases are marked. G2* marks those cells in G2/M which
were in S-phase at the time of addition of BrdU; Sf, cells which were initially in GI and had moved into S-phase; Gi', cells which
had moved into GI after addition of BrdU and S' and G2' are cells in their second cycle. The numbers on the cytograms give the
time in h after addition of BrdU. a-d, Untreated cells. e-h, Cells treated with 10 tM cisplatin for 2 h. e, f, BrdU added
immediately after treatment and samples taken at 8 and 24 h. g, h, BrdU added 24 h after treatment and samples taken after a
further 8 or 24 h incubation.
in both fractions was slower than that of untreated cells
(Figure 8a).
In some types of cell, apoptotic and necrotic cells can be
simultaneously quantified after a brief incubation with the
dye, Hoechst 33342, and addition of PI (Dive et al., 1992;
Ormerod et al., 1992; Sun et al., 1992). This method exploits
a change in the permeability of the plasma membranes of
apoptotic cells (Ormerod et al., 1993). Preliminary experi-
ments indicated that treatment of L1210 cells with the higher
doses of cisplatin altered the permeability of non-apoptotic
cells towards Hoechst 33342 and therefore this method was
not pursued in this system.
Discussion
Cell cycle progression
Our results clearly demonstrated that cells treated with cis-
platin suffer a slow-down in the traverse of S-phase followed
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Figure 6 DNA histograms and tracks from DNA gel electrophoresis of cells after various treatments. a, Untreated cells. b, Cells
10 h after treatment with 1I0 iM cisplatin for 2 h. c, Cells 10 h after treatment with 1I00JM cisplatin for 2 h. d, Untreated cells
approaching plateau phase of growth. e, Cells from d incubated for 5 h in PBS. f, Cells incubated for 17 h in arginine-deficient
medium. The numbers give the percentage of cells in a 'sub-GI' peak (a measure of apoptosis).
by a block in G2 - confirming previously published data. In
agreement with the detailed kinetic study of Demarcq et al.
(1992), there was little, if any, hindrance of the transition
from Gl into S phase and the division of cells treated in G2
was not affected. (This can be deduced from the lack of cells
in the G2 compartment in Figure 5e.) Cells blocked in G2
after 24 h had incorporated BrdU and had therefore
traversed S-phase after treatment. Cells treated in G2 divided
and moved through S before any arrest in the subsequent
G2, while cells treated in mid- and late S-phase had moved
through the first G2 and divided. These deductions can be
made by comparing Figure Sf with Figure 7C in Ormerod
and Kubbies (1992), which shows an example of cells, in
S-phase during treatment, subsequently suffering a block on
first reaching G2. In order to be arrested in G2, damage to
DNA alone is insufficient; there must also be replication of
DNA on the damaged template - an effect which has also
been observed in cells treated with alkylating agents
(Roberts, 1978). It has been suggested that cells are more
sensitive to cisplatin in GI (Roberts & Fraval, 1980) or at the
GI/S boundary (Dornish et al., 1987) compared with
S-phase. If the G2 block is a critical step in cell death, then
our observation that cells treated in GI become blocked in
G2 while those treated in S-phase move through G2 and
divide is consistent with this suggestion. Our data also
indicated that cells could be held up in G2 on the second
cycle (Figures 5 and 8).
Mechanism ofcell death
L1210 cells are susceptible to apoptosis, as evidenced by
nutritional deprivation, and apoptosis was induced in L1210
cells by high doses of cisplatin (>50gM) within 10 h of
treatment (Figure 6; Barry et al., 1990). The comparatively
rapid induction of apoptosis contrasted with the slower rate
of death associated with a G2 block.
At lower doses of cisplatin (>20gLM), cells become
blocked in G2. Our data are fully consistent with the sugges-
tion that there is a major decision point at this stage of the
cell cycle. The cells either eventually divide or stay in G2 and
die (Sorenson et al., 1990). The cells blocked in G2 enlarged
beyond the size of untreated cells in G2 (Figures 4 and 7)
and there was an increase in the PI-DNA fluorescence in
fixed cells and in Hoechst DNA fluorescence in unfixed cells.
The increased fluorescence could have been due to a change
in chromatin structure but, since increased staining was
observed both in viable cells stained with Hoechst 33342 and
in fixed cells stained with PI, more probably it reflected an
increase in the DNA content as a result of unregulated DNA
synthesis. At this time, two days after treatment, it is unlikely
that the large cells blocked in G2 could have subsequently
divided and they must have been committed to die. Indeed,
labelling with BrdU 24 h post treatment showed two popula-
tions of cells - one cycling and the other blocked in G2
(Figure 5). During this time (24-48 h), the cell number was
nearly static (Figure 1), which might be expected if one
population of cells was slowly dying and another was
dividing. Our data also showed that each time the cell pro-
gressed through G2 the block/divide decision had to be
repeated; a minority of cells were blocked in G2 on the
second or third cycle (Figures 5 and 7e).
By DNA gel electrophoresis, we could find little evidence
that the cells blocked in G2 died by apoptosis after doses of
cisplatin >20gM. When the cells were separated by centri-
fugal elutriation, we did not observe significant DNA ladder-
ing in the large cell fraction, which presumably contained
dying cells (Figure 8). Care has to be taken in interpreting
this result since the number of apoptotic cells at any given
time will depend on the balance between the rate of appear-
ance and rate of loss, that is if the rate of induction of
apoptosis is lower than the rate ofdisintegration of apoptotic
cells then the latter would not be observed. However apop-APOPTOSIS AND CELL DEATH BY CISPLATIN 99
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Figure 7 DNA histograms of ethanol-fixed L12010 cells. Cells
were treated for 2 h with 1O lM cisplatin, incubated at 37°C in
medium for 2 days and then separated into a large and small
fraction by centrifugal elutriation. a, Immediately before elutria-
tion. b, d, f, h, The large cell fraction (> 13.5 tLm diameter), and
c, e, g, i, the small cell fraction (<13.5 lim diameter), separated
by centrifugal elutriation: b, c, Immediately after separation; d, e,
24 h later; f, g, 48 h later; h, i, 72 h later.
totic cells were sufficiently stable to allow their observation
after either high doses of drug or nutritional deprivation
(Figure 6). Furthermore, Sorenson et al. (1990) were able to
observe extensive apoptosis in L1210 cells between 2 and 4
days after treatment with cisplatin.
There is an apparent discrepancy between our data and
those of Sorenson et al. (1990). While we and they both
observe apoptosis at high doses of cisplatin, they also
reported death through apoptosis of cells blocked in G2 of
the cell cycle after lower doses of drug. The resolution of this
difference lies in our observation that the induction of apop-
tosis can be influenced by the growth conditions. Our cells
were grown in HEPES-buffered RPMI-1640 medium plus
10% horse serum and had a doubling time of about 14 h.
Sorenson et al. (1990) grew their cells in McCoy's modified
Time (h)
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Figure 8 Cells separated by centrifugal elutriation 48 h after
treatment with 10 gM cisplatin as described in Figure 7. a,
Growth of cells after separation; V, large cells; A, small cells. b,
DNA gel electrophoresis of the cells after separation. Tracks 1-4,
small fraction; tracks 5-8, large fraction; tracks 1,5, immediately
after separation; 2,6, 24 h later; 3,7, 48 h later; 4,8, 72 h later.
Data in Figures 6 and 7 are the result of a single experiment. A
second experiment was performed with similar results.
medium with 15% calf serum under 5% carbon dioxide and
they have reported a cell doubling time of 24 h (Sorenson &
Eastman, 1988a). Under suboptimal conditions for growth, it
is possible that apoptosis was favoured.
Summary
We have confirmed that doses of cisplatin > 25 x IC50
rapidly induce apoptosis in L1210 cells. At lower doses of
cisplatin, cell death was caused by a failure of cells to over-
come a block in G2 of the cell cycle. While L1210 cells are
susceptible to the induction of apoptosis by other treatments,
we could find no evidence that they died from a G2 block,
induced by cisplatin, by this mechanism.
We thank Professor Kenneth Harrap for his advice, support and
encouragement and David Robertson for his help with the morpho-
logical observations. This work was supported by a programme
grant from the Cancer Research Campaign.
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